The American Food and Drug Administration recently approved a drug developed in Israel to treat Parkinson’s disease. Azilect, which is now available to patients, is the first Parkinson’s medication with once-daily dosage. Professors at the Technion-Israel Institute of Technology in Haifa worked alongside Israeli pharmaceutical company Teva to develop the drug.
Keep Jewish Stories in Focus.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.